tiprankstipranks
Trending News
More News >
Hisamitsu Pharmaceutical Co (JP:4530)
:4530
Japanese Market

Hisamitsu Pharmaceutical Co (4530) Financial Statements

Compare
0 Followers

Hisamitsu Pharmaceutical Co Financial Overview

Hisamitsu Pharmaceutical Co's market cap is currently ¥311.48B. The company's EPS TTM is ¥295.762; its P/E ratio is 14.44; and it has a dividend yield of 2.01%. Hisamitsu Pharmaceutical Co is scheduled to report earnings on April 10, 2025, and the estimated EPS forecast is ¥68.80. See an overview of income statement, balance sheet, and cash flow financials.
Mar 25Mar 24Mar 23Mar 22Mar 21
Income Statement
Total Revenue¥ 156.01B¥ 141.71B¥ 128.33B¥ 120.19B¥ 114.51B
Gross Profit¥ 91.20B¥ 78.97B¥ 72.70B¥ 70.07B¥ 69.17B
Operating Income¥ 18.90B¥ 13.17B¥ 11.60B¥ 9.34B¥ 10.67B
EBITDA¥ 35.05B¥ 24.37B¥ 16.55B¥ 13.66B¥ 14.75B
Net Income¥ 21.76B¥ 13.97B¥ 11.74B¥ 9.66B¥ 9.25B
Balance Sheet
Cash & Short-Term Investments¥ 129.12B¥ 125.32B¥ 136.87B¥ 142.43B¥ 136.00B
Total Assets¥ 343.07B¥ 328.78B¥ 313.92B¥ 302.86B¥ 299.86B
Total Debt¥ 3.86B¥ 2.10B¥ 2.29B¥ 2.46B¥ 1.60B
Net Debt¥ -110.66B¥ -110.36B¥ -119.86B¥ -126.83B¥ -112.65B
Total Liabilities¥ 63.66B¥ 61.70B¥ 55.51B¥ 47.98B¥ 46.06B
Stockholders' Equity¥ 276.83B¥ 264.88B¥ 256.36B¥ 253.16B¥ 252.29B
Cash Flow
Free Cash Flow¥ 5.14B¥ 5.15B¥ 4.82B¥ 15.01B¥ 1.90B
Operating Cash Flow¥ 18.77B¥ 18.19B¥ 12.73B¥ 19.20B¥ 5.29B
Investing Cash Flow¥ 17.56B¥ -2.51B¥ -23.87B¥ -13.06B¥ 7.82B
Financing Cash Flow¥ -15.85B¥ -16.69B¥ -14.69B¥ -15.19B¥ -7.19B
Currency in JPY

Hisamitsu Pharmaceutical Co Earnings and Revenue History

Hisamitsu Pharmaceutical Co Debt to Assets

Hisamitsu Pharmaceutical Co Cash Flow

Hisamitsu Pharmaceutical Co Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis